Abstract
Some brain-derived neurotrophic factor (BDNF)-targeted miRNAs such as miR-30a-5p may be associated with alcohol addiction; however, their relationship with alcohol withdrawal syndrome (AWS) is not described. We aimed to measure serum BDNF concentration and relative content of miR-30a-5p over the course of alcohol abstinence and compare results with the clinics of AWS. Apart from that, we studied the serum relative content of miR-122, a miRNA that does not target BDNF but is associated with alcohol use disorder. Serum BDNF concentration increases over the course of alcohol abstinence. In contrast, the relative content of miR-122, but not miR-30a-5p, decreased. Moreover, miR-122 (but not miR-30a-5p) negatively correlated with serum BDNF concentrations in the course of AWS. The relative content of miR-122 negatively correlated with depression and anxiety levels on day 8 of abstinence. According to multiple regression analysis, the severity of craving for alcohol and cognitive disturbances may be predictors of serum BDNF concentration on day 21 of abstinence, and vice versa. Thus, serum BDNF concentration and relative content of miR-122 are associated with some aspects of AWS clinical manifestations and may dynamically reflect AWS severity.
Similar content being viewed by others
REFERENCES
Girard, M., Malauzat, D., and Nubukpo, P., World J. Biol. Psychiatry, 2019, vol. 20, no. 1, pp. 76–90. https://doi.org/10.1080/15622975.2017.1349338
Coccini, T., Ottonello, M., Spigno, P., Malovini, A., Fiabane, E., Roda, E., Signorini, C., and Pistarini, C., Alcohol, 2021, vol. 94, pp. 43–56. https://doi.org/10.1016/j.alcohol.2021.04.004
Harper, C. and Kril, J., J. Neurol. Neurosurg. Psychiatry, 1985, vol. 48, no. 3, pp. 211–217. https://doi.org/10.1136/jnnp.48.3.211
Fein, G., di Sclafani, V., Cardenas, V.A., Gold-mann, H., Tolou-Shams, M., and Meyerhoff, D.J., Alcohol. Clin. Exp. Res., 2002, vol. 26, no. 4, pp. 558–564.
Pfefferbaum, A., Rosenbloom, M., Rohlfing, T., and Sullivan, E.V., Biol. Psychiatry, 2009, vol. 65, no. 8, pp. 680–690. https://doi.org/10.1016/j.biopsych.2008.10.039
Altshuler, V.B., Serova, L.A., Kravchenko, S.L., Korolkov, A.I., Zaritskaya, V.A., and Khodikina, L.A., Zh. Vopr. Narkol., 2013, vol. 6, pp. 176–191.
Topiwala, A., Allan, C.L., Valkanova, V., Zsoldos, E., Filippini, N., Sexton, C., Mahmood, A., Fooks, P., Singh-Manoux, A., Mackay, C.E., Kivimäki, M., and Ebmeier, K.P., BMJ, 2017, vol. 357, p. j2353. https://doi.org/10.1136/bmj.j2353
Ron, D. and Berger, A., Psychopharmacology (Berlin), 2018, vol. 235, no. 6, pp. 1727–1743. https://doi.org/10.1007/s00213-018-4882-z
Liran, M., Rahamim, N., Ron, D., and Barak, S., Cold Spring Harb. Perspect. Med., 2020, vol. 10, no. 12, p. a039271. https://doi.org/10.1101/cshperspect.a039271
Kethawath, S.M., Jain, R., Dhawan, A., and Sarkar, S., Indian J. Psychiatry, 2020, vol. 62, no. 1, pp. 15–20. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_134_19
Mach, A. and Gromadzka, G., Alcohol Drug. Addict., 2020, vol. 33, no. 4, pp. 313–340. https://doi.org/10.5114/ain.2020.104815
Varendi, K., Mätlik, K., and Andressoo, J.O., Cell. Mol. Life Sci., 2015, vol. 72, no. 9, pp. 1779–1794. https://doi.org/1007/s00018-015-1836-z
Darcq, E., Warnault, V., Phamluong, K., Besserer, G.M., Liu, F., and Ron, D., Mol. Psychiatry, 2015, vol. 20, no. 10, pp. 1219–1231. https://doi.org/10.1038/mp.2014.120
Ehinger, Y., Phamluong, K., Darevesky, D., Welman, M., Moffat, J.J., Sakhai, S.A., White-ley, E.L., Berger, A.L., Laguesse, S., Farokhnia, M., Leggio, L., Lordkipanidzé, M., and Ron, D., Addict. Biol., 2021, vol. 26, no. 2, p. e12890. https://doi.org/10.1111/adb.12890
Ignacio, C., Hicks, S.D., Burke, P., Lewis, L., Szombathyne-Meszaros, Z., and Middleton, F.A., BMC Neurosci., 2015, vol. 16, p. 55. https://doi.org/10.1186/s12868-015-0195-x
Torres, J.L., Novo-Veleiro, I., Manzanedo, L., Alvela-Suárez, L., Macías, R., Laso, F.J., and Marcos, M., World J. Gastroenterol., 2018, vol. 24, no. 36, pp. 4104–4118. https://doi.org/10.3748/wjg.v24.i36.4104
Neufeld, M., Bunova, A., Ferreira-Borges, C., Bryun, E., Fadeeva, E., Gil, A., Gornyi, B., Khaltourina, D., Koshkina, E., Nadezhdin, A., Tetenova, E., Vujnovic, M., Vyshinsky, K., Yurasova, E., and Rehm, J., Subst. Abuse Treat. Prev. Policy, 2021, vol. 16, no. 1, p. 76. https://doi.org/10.1186/s13011-021-00404-8
Sobell, L.C. and Sobell, M.B., Measuring Alcohol Consumption: Psychosocial and Biological Methods, Litten, R.Z. and Allen, J.P., Eds., Humana Press, Totowa, NJ, 1992, pp. 41–72.
Pittman, B., Gueorguieva, R., Krupitsky, E., Rudenko,A.A., Flannery, B.A., and Krystal, J.H., Clin. Exp. Res., 2007, vol. 31, no. 4, pp. 612–618. https://doi.org/10.1111/j.1530-0277.2007.00345.x
Flannery, B.A., Volpicelli, J.R., and Pettinati, H.M., Alcohol. Clin. Exp. Res., 1999, vol. 23, no. 8, pp. 1289–1295.
Ivanets, N.N., Kinkulkina, M.A., Avdeeva, T.I., and Sysoeva, V.P., Zh. Nevrol. Psikhiatr. im. S. S. Korsakova, 2016, vol. 116, no. 6, pp. 31–41.
Makhortova, I.S. and Shiryaev, O.Yu., Zh. Nevrol. Psikhiatr. im. S.S. Korsakova, 2017, vol. 117, no. 11, pp. 64–68.
Freud, T., Vostrikov, A., Dwolatzky, T., Punchik, B., and Press, Y., Front. Med. (Lausanne), 2020, vol. 7, p. 447. https://doi.org/10.3389/fmed.2020.00447
Donati, S., Ciuffi, S., and Brandi, M.L., Int. J. Mol. Sci., 2019, vol. 20, no. 18, p. 4353. https://doi.org/10.3390/ijms20184353
Wu, S.Y., Chen, C.Y., Huang, T.L., and Tsai, M.C., Medicine (Baltimore), 2020, vol. 99, no. 17, p. e19938. https://doi.org/10.1097/MD.0000000000019938
Guo, L., Yin, M., and Wang, Y., Oncol. Lett., 2018, vol. 16, no. 3, pp. 3842–3848. https://doi.org/10.3892/ol.2018.9118
Heberlein, A., Muschler, M., Wilhelm, J., Frieling, H., Lenz, B., Gröschl, M., Kornhuber, J., Bleich, S., and Hillemacher, T., Prog. Neuropsychopharmacol. Biol. Psychiatry, 2010, vol. 34, no. 6, pp. 1060–1064. https://doi.org/10.1016/j.pnpbp.2010.05.025
Huang, M.C., Chen, C.H., Chen, C.H., Liu, S.C., Ho, C.J., Shen, W.W., and Leu, S.J., Alcohol Alcohol., 2008, vol. 43, no. 3, pp. 241–245. https://doi.org/10.1093/alcalc/agm172
Joe, K.H., Kim, Y.K., Kim, T.S., Roh, S.W., Choi, S.W., Kim, Y.B., Lee, H.J., and Kim, D.J., Alcohol. Clin. Exp. Res., 2007, vol. 31, no. 11, pp. 1833–1838. https://doi.org/10.1111/j.1530-0277.2007.00507.x
Portelli, J., Farokhnia, M., Deschaine, S.L., Battista,J.T., Lee, M.R., Li, X., Ron, D., and Leggio, L., Alcohol, 2020, vol. 89, pp. 75–83. https://doi.org/10.1016/j.alcohol.2020.07.009
Levchuk, L.A., Meeder, E.M.G., Roschina, O.V., Loonen, A.J.M., Boiko, A.S., Michalitskaya, E.V., Epimakhova, E.V., Losenkov, I.S., Simutkin, G.G., Bokhan, N.A., Schellekens, A.F.A., and Ivanova, S.A., Front. Psychiatry, 2020, vol. 11, p. 296. https://doi.org/10.3389/fpsyt.2020.00296
Miao, Z., Zhang, J., Li, Y., Li, X., Song, W., Sun, Z.S., and Wang, Y., Neuropharmacology, 2019, vol. 159, p. 107589. https://doi.org/10.1016/j.neuropharm.2019.03.032
Cattaneo, A., Suderman, M., Cattane, N., Mazzelli, M., Begni, V., Maj, C., D’Aprile, I., Pariante, C.M., Luoni, A., Berry, A., Wurst, K., Hommers, L., Domschke, K., Cirulli, F., Szyf, M., Menke, A., and Riva, M.A., Neurobiol. Stress, 2020, vol. 13, p. 100271. https://doi.org/10.1016/j.ynstr.2020.100271
Han, C., Bae, H., Won, S.D., Roh, S., and Kim, D.J., Ann. Gen. Psychiatry, 2015, vol. 14, p. 30. https://doi.org/10.1186/s12991-015-0065-z
Nubukpo, P., Ramoz, N., Girard, M., Malauzat, D., and Gorwood, P., Alcohol. Clin. Exp. Res., 2017, vol. 41, no. 7, pp. 1280–1287. https://doi.org/10.1111/acer.13414
Funding
The study was carried out within the state assignment on the topic Study of the Pathogenetic Mechanisms of the Formation of Addiction to Psychoactive Substances Using Genetic, Biochemical, Immunological, Neurophysiological, and Neurocognitive Approaches (reg. no. 121041300174-8).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare no conflict of interest.
Ethical approval. The study protocol complied with the Declaration of Helsinki and was approved by the local ethics committee (protocol no. 36/9 of December 6, 2021). All patients gave written informed consent to participate in the study.
Additional information
Translated by A. Deryabina
Rights and permissions
About this article
Cite this article
Peregud, D.I., Korolkov, A.I., Baronets, V.Y. et al. Contents of BDNF, miR-30a-5p AND miR-122 during Alcohol Withdrawal Syndrome. Biochem. Moscow Suppl. Ser. B 16, 353–363 (2022). https://doi.org/10.1134/S1990750822040060
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750822040060